- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/72 - ReceptorsCell surface antigensCell surface determinants for hormones
Patent holdings for IPC class C07K 14/72
Total number of patents in this class: 925
10-year publication summary
|
53
|
79
|
77
|
94
|
79
|
71
|
79
|
74
|
58
|
28
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1151 |
39 |
| The Regents of the University of California | 19780 |
20 |
| Vib VZW | 860 |
18 |
| Vrije Universiteit Brussel | 495 |
18 |
| Regeneron Pharmaceuticals, Inc. | 4201 |
15 |
| The Board of Trustees of the Leland Stanford Junior University | 6322 |
13 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2128 |
13 |
| Heptares Therapeutics Limited | 114 |
12 |
| Hanmi Pharm. Co., Ltd. | 567 |
10 |
| Nxera Pharma UK Limited | 130 |
10 |
| Amgen Inc. | 4012 |
9 |
| Board of Regents, The University of Texas System | 5736 |
9 |
| President and Fellows of Harvard College | 5932 |
9 |
| Cornell University | 3270 |
9 |
| Rhythm Pharmaceuticals, Inc. | 69 |
9 |
| H. Lundbeck A/S | 1189 |
9 |
| Massachusetts Institute of Technology | 9975 |
8 |
| Duke University | 3049 |
8 |
| Asterion Limited | 23 |
8 |
| The Johns Hopkins University | 5626 |
7 |
| Other owners | 672 |